| James Thomas Quann, MD | |
|
1000 Langworthy St, Suite 140, Dubuque, IA 52001-7313 | |
| (563) 584-3450 | |
| (563) 584-3171 |
| Full Name | James Thomas Quann |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1000 Langworthy St, Dubuque, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447412309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | R-8481 (Iowa) | Secondary |
| 208600000X | Surgery | 40889 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Thomas Quann, MD 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4100 | James Thomas Quann, MD 1000 Langworthy St, Suite 140, Dubuque, IA 52001-7313 Ph: (563) 584-3450 |
News Archive
MR Solutions will be displaying its latest ground-breaking preclinical cryogen-free MRI imaging systems at ISMRM in Singapore from May 7 to 13.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
Positron emission tomography (PET) could be an important tool for identifying non-Hodgkin's lymphoma patients who are likely to respond well to treatment with 90 ibritumomab tiuxetan (IT)-the first radioimmunotherapy treatment approved for use by the U.S. Food and Drug Administration, said researchers at the Society of Nuclear Medicine's 55th Annual Meeting.
A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis - often-fatal conditions that affect tens of millions of Americans.
The American College of Cardiology's Cardiovascular Summit will feature several poster presentations on care delivery, cost reduction and quality improvement that offer innovative concepts to combat access to care, especially during the ongoing COVID-19 pandemic and as the broader health care system works to improve health equity.
› Verified 2 days ago
Joseph Bernard Fuller, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3450 Fax: 563-584-3171 | |
Dr. Phillip Gabriel Bailey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St Ste 200, Dubuque, IA 52001 Phone: 563-557-7000 | |
Christopher Omerza, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3450 Fax: 563-584-3171 | |
Jacob Levi Wagner, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St, Suite 200, Dubuque, IA 52001 Phone: 563-557-7000 Fax: 563-589-4050 | |
Dr. Garrett William Fleming, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3450 Fax: 563-584-3171 | |
Roger Arthur Ott Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3450 Fax: 563-584-3171 | |
Keith Alan Shaw, MD Surgery Medicare: Medicare Enrolled Practice Location: 1515 Delhi St, Ste 200, Dubuque, IA 52001 Phone: 563-557-7000 Fax: 563-589-4050 |